Compare Cronos Group Inc (CRON) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Kinder Morgan Inc — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.11B), while Kinder Morgan Inc trades at $31.6 (market cap $69.90B). The key difference: Kinder Morgan Inc is far larger — about 63× Cronos Group Inc's market cap, and Kinder Morgan Inc pays a 3.76% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | KMI | |
|---|---|---|
Market Cap | $1.11B | $69.90B |
Sector | Health | Energy |
52-Week High | $3.27 | $34.31 |
52-Week Low | $2.30 | $25.84 |
Enterprise Value | $310.67M | $101.95B |
Dividend Yield | — | 3.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.
Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.
Kinder Morgan (KMI) trades at $30.85, down 1.37% over the past day, with a bearish technical signal from moving averages and oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $0.37 versus $0.32 expected, and raised full-year guidance. Revenue for 2025 was $16.94 billion, with net income of $3.06 billion and a profit margin of 18.04%. Recent news highlights growth in natural gas infrastructure driven by LNG and power demand, supporting a dividend of $0.30 per share.
KMI presents a mixed outlook; fundamentals are solid with earnings beats and a robust project pipeline, but technical indicators signal near-term caution. Investment opportunities include dividend income and exposure to energy infrastructure growth, while risks involve debt levels and oil price volatility. Analyst consensus is nearly evenly split between buy and hold ratings, reflecting balanced sentiment amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
